Skip to content

Protective Variable Ventilation for Open Abdominal Surgery

Effects of Variable Tidal Volumes During Open Abdominal Surgery on Lung Function and Systemic Inflammation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01683578
Acronym
PROVAR
Enrollment
50
Registered
2012-09-12
Start date
2012-09-30
Completion date
2013-09-30
Last updated
2016-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Development of Pulmonary Dysfunction Following Open Abdominal Surgery

Keywords

mechanical ventilation, lung function, abdominal surgery, open, systemic inflammation

Brief summary

Variable ventilation has been shown to improve lung function and reduce lung damage as well as inflammation in different models of the acute respiratory distress syndrome. Also, variable ventilation is able to recruit lungs. The present study will investigate whether variable as compared to non-variable ventilation improves post-operative lung function and reduces systemic inflammation in patients submitted to open abdominal surgery.

Interventions

Sponsors

Technische Universität Dresden
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* elective open abdominal surgery * ASA classification 2-3 * age between 18 und 85 yrs * expected duration of surgery \> 3 h * expected extubation in the operation room * written informed consent

Exclusion criteria

* chronic lung disease (except to COPD stadium I and II, and asthma) * Body Mass Index (BMI) \> 40 * allergy to one of the drugs to be used for general anesthesia * participation in another interventional trial within 4 weeks before enrollment * addiction or any other disease that may interfere with the capacity of giving informed consent * pregnant or breastfeeding women * women in reproductive age, except to those who fulfill one of the following: * post-menopause (12 months natural amenorrhoea, or 6 months amenorrhoea and serum FSH \> 40 mlU/ml * post-operative (6 weeks after two-sided ovariectomy) * routine and correct use of anticonceptional methods with failure rate \< 1 % per year * sexually not active * vasectomy of the partner * indication of low compliance with the protocol * contraindication for MRI examination

Design outcomes

Primary

MeasureTime frameDescription
Forced vital capacityPreoperative until 5th postoperative dayForced vital capacity is assessed on the first postoperative day

Secondary

MeasureTime frameDescription
Peak expiratory flowPreoperative until 5th postoperative day
Forced expiratory volume after 1 secPreoperative until 5th postoperative dayForced expiratory volume after 1 sec (FEV1) on first postoperative day
PaO2/FIO2Preoperative until 5th postoperative dayPaO2/FIO2 during the intraoperative period
Arterial partial CO2 pressurePreoperative until 5th postoperative dayPacO2 on the first postoperative day
AtelectasisPreoperative until 5th postoperative dayAmount of lung atelectasis on the first postoperative day
Postoperative pulmonary complicationsPreoperative until discharge from hospitalDevelopment of postoperative pulmonary complications
Inflammation markersPreoperative until 5th postoperative dayConcentrations of interleukine(IL)-6, IL-8 and tumor necrosis factor(TNF)-alpha in plasma
Distribution of ventilationPreoperative until 5th postoperative dayDistribution of ventilation in lungs

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026